Aptinyx Recommences Patient Recruitment in Phase 2 Study of NYX-2925 in Patients with Fibromyalgia Resuming study following suspension of enrollment due to escalation of COVID-19 pandemic Data readout expected in 1H 2022 Also on track to recommence separate Phase 2...
Arvinas Announces Pipeline Programs Targeting Validated and Classically “Undruggable” Disease-Causing Proteins NEW HAVEN, Conn., Oct. 14, 2020 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs...
TigerConnect Closes $45M Series D To Meet Soaring DemandCare Team Collaboration Platform Revenue Grew 30% Since COVID-19 Onset, Added 1,000 Hospital Systems SANTA MONICA, California — October 8, 2020 — TigerConnect, healthcare’s most widely adopted care team...
Kit Check and Sandoz Collaborate to Launch RFID-tagged Generic Injectables in October 2020 DoseID members, Kit Check and Sandoz, have agreed to launch RFID-tagged injectable medicines Two NDCs of Sandoz RFID-tagged medicines will be available in October 2020, with...
Kit Check Extends Partnership with Premier Inc. in Multi-Year Contract to Further Advance Pharmacy Visibility with Diversion Detection Software and Medication Management WASHINGTON, D.C.–(BUSINESS WIRE)–Kit Check, the leader in automated and intelligent medication...
Recent Comments